Back to Search
DENNIS CHI, MD
MD
Gynecologic Oncology Physician
NPI: 1245215565IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
187616(NY)
CMS Specialties
PrimaryGYNECOLOGICAL ONCOLOGY
Additional
GENERAL SURGERY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1990
Research & Publications (20)
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
PMID 19395008·Gynecol Oncol·2009
8-other
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
PMID 19100916·Gynecol Oncol·2009
8-other
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
PMID 17950784·Gynecol Oncol·2008
8-other
Cytoreduction vs. neoadjuvant chemotherapy for ovarian cancer.
PMID 19041036·Gynecol Oncol·2008
4-observational
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
PMID 17971592·J Clin Oncol·2007
3-trial
Extended pelvic resection of iliacus muscle and femoral nerve for isolated recurrent uterine cancer.
PMID 17182089·Gynecol Oncol·2007
8-other
Distal partial gastrectomy and gastrojejunal anastomosis for recurrent ovarian cancer.
PMID 17166565·Gynecol Oncol·2007
8-other
Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer.
PMID 16337997·Gynecol Oncol·2006
8-other
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
PMID 16714056·Gynecol Oncol·2006
8-other
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
PMID 16572412·Cancer·2006
8-other
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers.
PMID 15902166·Am J Obstet Gynecol·2005
4-observational
Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy.
PMID 15507933·Am J Obstet Gynecol·2004
8-other
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
PMID 15350354·Gynecol Oncol·2004
8-other
The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions.
PMID 15297166·Gynecol Oncol·2004
8-other
Major hepatectomy at interval debulking for stage IV ovarian carcinoma: a case report.
PMID 12468355·Gynecol Oncol·2002
5-case
Surgical management of advanced or recurrent endometrial cancer.
PMID 11551132·Surg Clin North Am·2001
6-review
The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents.
PMID 11695806·Eur J Gynaecol Oncol·2001
8-other
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
PMID 11520151·Gynecol Oncol·2001
8-other
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
PMID 10785469·Gynecol Oncol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (646) 227-3813
Quick Facts
- NPI
- 1245215565
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile